Literature DB >> 1306660

Quality of life following surgery for abdominal aortic aneurysm.

T R Magee1, D J Scott, A Dunkley, J St Johnston, W B Campbell, R N Baird, M Horrocks.   

Abstract

Repair of abdominal aortic aneurysm (AAA) carries a considerable rate of morbidity and mortality, but little information exists on the quality of life following this procedure. During 1988 and 1989, in two hospitals, 211 patients (186 men and 25 women; median age 74 (range 48-87) years) underwent surgery for AAA. There were 77 ruptured aneurysms and 134 electively repaired. Of these, 38 patients died in hospital (27 ruptured, 11 elective); by the time of review a further eight (one ruptured, seven elective) had died from unrelated causes. Of the 165 survivors, 131 (45 ruptured, 86 elective) were reviewed and questioned as to their physical and mental state before and after surgery. Using the Rosser index, a value for quality of life before and after surgery was calculated (1.0, good; 0, dead). The value for the elective group was 0.94 before operation and 0.96 after, but in the ruptured group fell from 0.98 before surgery to 0.87 afterwards. This study shows that patients undergoing elective surgery for repair of AAA retain good quality of life. By contrast, patients surviving emergency surgery following this procedure seem to suffer a deterioration in life quality, which must be endured for the same expected lifetime as that for the elective group. These results support the need for a national AAA ultrasonographic screening programme.

Entities:  

Mesh:

Year:  1992        PMID: 1306660     DOI: 10.1002/bjs.1800791009

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  10 in total

1.  The economic impact of Parkinson's disease. An estimation based on a 3-month prospective analysis.

Authors:  R C Dodel; M Singer; R Köhne-Volland; T Szucs; B Rathay; E Scholz; W H Oertel
Journal:  Pharmacoeconomics       Date:  1998-09       Impact factor: 4.981

Review 2.  Current treatment strategies for ruptured abdominal aortic aneurysm.

Authors:  Andreas S Peters; Maani Hakimi; Philipp Erhart; Michael Keese; Thomas Schmitz-Rixen; Markus Wortmann; Moritz S Bischoff; Dittmar Böckler
Journal:  Langenbecks Arch Surg       Date:  2016-04-07       Impact factor: 3.445

3.  A cardiovascular extension of the Health Measurement Questionnaire.

Authors:  A J Martin; P P Glasziou; R J Simes
Journal:  J Epidemiol Community Health       Date:  1999-09       Impact factor: 3.710

4.  Health-related quality of life in endstage renal failure.

Authors:  C M Gudex
Journal:  Qual Life Res       Date:  1995-08       Impact factor: 4.147

5.  Ruptured aortic aneurysm: the decision not to operate.

Authors:  D F Hewin; W B Campbell
Journal:  Ann R Coll Surg Engl       Date:  1998-05       Impact factor: 1.891

6.  Long term relative survival after surgery for abdominal aortic aneurysm in western Australia: population based study.

Authors:  P E Norman; J B Semmens; M M Lawrence-Brown; C D Holman
Journal:  BMJ       Date:  1998-09-26

7.  Outcome and quality of life in patients treated for abdominal aortic aneurysms: a single center experience.

Authors:  Florian Dick; Véronique Grobéty; Franz F Immer; Dai Do Do; Hannu Savolainen; Thierry P Carrel; Jürg Schmidli
Journal:  World J Surg       Date:  2008-06       Impact factor: 3.352

8.  Screening for abdominal aortic aneurysms in men: a Canadian perspective using Monte Carlo-based estimates.

Authors:  Bernard Montreuil; James Brophy
Journal:  Can J Surg       Date:  2008-02       Impact factor: 2.089

9.  Long-term survival and quality of life after open abdominal aortic aneurysm repair.

Authors:  Tim K Timmers; Joost A van Herwaarden; Gert-Jan de Borst; Frans L Moll; Luke P H Leenen
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

Review 10.  Ruptured abdominal aortic aneurysm: the state of play.

Authors:  Michael Gawenda; Jan Brunkwall
Journal:  Dtsch Arztebl Int       Date:  2012-10-26       Impact factor: 5.594

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.